Chikungunya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials

A Phase 3 Safety, Immunogenicity, Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317
Condition:   Chikungunya Virus Interventions:   Biological: CHIKV VLP/adjuvant;   Biological: Placebo Sponsor:   Emergent BioSolutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2021 Category: Research Source Type: clinical trials

A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317
Condition:   Chikungunya Virus Interventions:   Biological: CHIKV VLP/adjuvant;   Biological: Placebo Sponsor:   Emergent BioSolutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2021 Category: Research Source Type: clinical trials